Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Milrinone and Calcium Supplement

Research Papers that Mention the Interaction

Currently available inotropes, such as dobutamine and milrinone , increase cardiac contractility at the expense of increased intracellular concentrations of calcium and cAMP, contributing to increased heart rate, hypotension, arrhythmias, and mortality.
Heart Failure Reviews  •  2009  |  View Paper
In isolated rabbit cardiomyocytes, milrinone (>10 μM) caused greater elevations in intracellular cAMP and calcium than cilostazol.
Cardiovascular Drugs and Therapy  •  2004  |  View Paper
A submaximal, but not a maximal, inotropic effect of ouabain could be increased by the addition of milrinone; in contrast, both ouabain and calcium increased the maximal inotropic effect of milrinone by 1.7±0.2 mN and 2.7±0.3 mN, respectively.
Klinische Wochenschrift  •  2005  |  View Paper
Aim: Milrinone , a phosphodiesterase III inhibitor, exerts positive inotropic effects which induce an increase in the intracellular calcium concentration by raising the cyclic adenosine monophosphate level in cardiac muscle.
Acta anaesthesiologica Scandinavica  •  2003  |  View Paper
Digoxin (10(-6) mol/L) and milrinone (10(-5) mol/L) increased LV contractility with a concomitant increase in Ca2+ transient, and the relative increase of Ca2+ transient produced by milrinone was much more than that by digoxin.
Journal of pharmacological and toxicological methods  •  1996  |  View Paper
It is concluded that milrinone inhibits vascular smooth muscle contractility by probably acting at multiple sites to decrease the availability of intracellular free Ca required for activation.
European journal of pharmacology  •  1988  |  View Paper
These data suggest that the diminished inotropic effect of milrinone in the fetus may be due, at least in part, to the decreased inotropism of cyclic AMP and calcium.
Pediatric Research  •  1987  |  View Paper
The effects of milrinone were studied in ferret papillary muscle stimulated at various rates and temperatures from 23° to 36° C. In voltage-clamp experiments, 50 μg/ml (0.237 mM) milrinone induced a 2.1-fold increase in calcium current at 28° or 36°C.
Circulation research  •  1986  |  View Paper
In conclusion, milrinone and its analogue amrinone appear to increase the entry of calcium into myocardial cells, primarily by increasing the influx of this cation during the slow inward calcium current.
Circulation  •  1986  |  View Paper
Preliminary findings indicate, however, that milrinone may play a role in initiating an earlier spontaneous release of Ca++ from the sarcoplasmic reticulum.
Circulation  •  1986  |  View Paper
Show More